- Cyclacel Pharmaceuticals (CYCC, Financial) announces a quarterly dividend of $0.15 per share.
- Ex-dividend date is April 29, with payment on May 1.
- Analyst forecasts imply significant upside potential for CYCC shares.
Cyclacel Pharmaceuticals (CYCC) has declared a quarterly dividend of $0.15 per share. The dividend will be paid out on May 1 to shareholders who are recorded by April 29. This makes April 29 the key ex-dividend date for those looking to be eligible for the payment.
Wall Street Analysts Forecast
The outlook from Wall Street analysts remains intriguing for Cyclacel Pharmaceuticals Inc (CYCC, Financial). Based on the one-year price targets provided by a single analyst, the average target price is set at $1.00. Notably, this target depicts both the high and low estimate, indicating a uniform prediction. This target suggests a potential upside of 336.68% compared to the current share price of $0.23. For more in-depth analysis, visit the Cyclacel Pharmaceuticals Inc (CYCC) Forecast page.
Turning to consensus recommendations, the average brokerage recommendation for Cyclacel Pharmaceuticals Inc (CYCC, Financial) stands at 3.0. This position equates to a "Hold" rating on a scale where 1 signifies a Strong Buy and 5 indicates a Sell. Such ratings reflect a cautious sentiment from brokers regarding the stock's current status.
